CCND1 and esophageal cancer: Cyclin D1 is a therapeutic target for esophageal cancer, and the nanoparticles exerted selectivity, causing a significant decrease in cyclin D1 expression in the KYSE30 cells, while in the normal cells it was at least 2-fold higher [92].